Biopharmaceutical company
Issues related to Pharmacy Benefit Manager reform included in S. 1339 - Pharmacy Benefit Manager Reform Act, H.R. 3281 - The Transparent PRICE Act, S.127 PBM Transparency Act of 2023, H.R. 4507 -Transparency in Coverage Act of 2023, S. 1967 - PBM Act, S.2973 - Modernizing and Ensuring PBM Accountability Act, H.R. 5378: Lower Costs, More Transparency Act, S.3430: Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023 Access to DME-infused drugs in the home, H.R. 5397, the Joe Fiandra Access to Home Infusion Act of 2023 (Reps. Fitzpatrick and Dunn) Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 H.R. 5539 - ORPHAN Cures Act H.R.2880 - Protecting Patients Against PBM Abuses Act Issues related to access and coverage in Medicare program. Support for H.R.5547/S.476 - Maintaining Investments in New Innovation Act
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
ALANNA TEMME JOHN MCMANUS LAWREN D GEER ALANNA TEMME (LD, Rep. Jon Porter) JOHN MCMANUS (Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas)
LD, Rep. Jon Porter Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas